影响癌症免疫监视的远距离微生物机制
Laurence Zitvogel1, Marine Fidelle2, Guido Kroemer3
1Gustave Roussy Cancer Campus, Villejuif, France; Institut National de la Santé Et de la Recherche Médicale (INSERM) UMR 1015, ClinicObiome, Équipe Labellisée-Ligue Nationale contre le Cancer, Villejuif, France; Université Paris-Saclay, Ile-de-France, France; Center of Clinical Investigations in Biotherapies of Cancer (BIOTHERIS), Villejuif, France.
Immunity
|August 16, 2024
概括
肠道微生物群通过调节抗瘤免疫力,影响癌症免疫疗法的有效性. 了解微生物转移和免疫细胞迁移是改善癌症治疗结果的关键.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 肠道微生物群在调节对各种抗原的免疫反应中起着至关重要的作用,包括针对瘤的特定抗原.
- 肠道微生物群的干扰会显著损害癌症免疫治疗的有效性,对患者的治疗结果产生负面影响.
- 肠道微生物群的影响超越了胃肠道,影响全身免疫和抗瘤反应.
研究的目的:
- 审查肠道微生物群对抗瘤免疫的长距离影响.
- 阐明肠道微生物群控制对瘤的免疫反应的机制.
- 突出目前对肠道微生物群,瘤免疫力和微生物转移之间的相互作用的理解和知识差距.
主要方法:
- 文献综述侧重于肠道微生物群在癌症免疫治疗中的作用.
- 分析包括微生物转移,白细胞迁移和微生物代谢物的机制.
- 讨论瘤微生物群在调节免疫细胞和微生物贩运到瘤部位方面的重要性.
主要成果:
- 肠道微生物群显著影响全身免疫和抗瘤反应.
- 机制包括微生物转移到瘤中,肠系白细胞迁移到瘤中,以及微生物产品的作用.
- 这些途径与瘤微生物群的作用之间的确切关系需要进一步研究.
结论:
- 肠道微生物群是对抗瘤免疫反应的关键决定因素,并影响癌症免疫治疗.
- 了解从肠道到瘤的微生物和免疫细胞贩运,对于改善癌症治疗至关重要.
- 需要进一步的研究,以充分阐明控制癌症免疫中的肠-瘤轴的复杂相互作用.
相关概念视频
Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cytotoxic T Cells-mediated Immune Response
861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


